Functional variant in complement C3 gene promoter and genetic susceptibility to temporal lobe epilepsy and febrile seizures

PLoS ONE

Volumn 5, Issue 9, 2010, Pages 1-8

  Jamali, Sarah ^a,i   Salzmann, Annick ^b   Perroud, Nader ^b   Ponsole Lenfant, Magali ^c   Cillario, Jennifer ^c   Roll, Patrice ^a   Roeckel Trevisiol, Nathalie ^a   Crespel, Ariel ^d   Balzar, Jorg ^e   Schlachter, Kurt ^f   Gruber Sedlmayr, Ursula ^g   Pataraia, Ekaterina ^e   Baumgartner, Christoph ^h   Zimprich, Alexander ^e   Zimprich, Fritz ^e   Malafosse, Alain ^b   Szepetowski, Pierre ^a,c  

^a AIX MARSEILLE UNIVERSITY   (France)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c INSERM   (France)

^d MONTPELLIER UNIVERSITY HOSPITAL   (France)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f Medical University of Graz ^*  (Austria)

^g MEDICAL UNIVERSITY OF GRAZ   (Austria)

^h UNIVERSITY OF VIENNA   (Austria)

ⁱ AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; MICROSATELLITE DNA;

ARTICLE; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; FEBRILE CONVULSION; FEMALE; GENE ACTIVITY; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOME SIZE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NUCLEOTIDE SEQUENCE; REPORTER GENE; SEIZURE SUSCEPTIBILITY; TEMPORAL LOBE EPILEPSY; ADOLESCENT; ADULT; CASE CONTROL STUDY; CHILD; GENETIC PREDISPOSITION; GENETICS; PRESCHOOL CHILD; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMPLEMENT C3; EPILEPSY, TEMPORAL LOBE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; MICROSATELLITE REPEATS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SEIZURES, FEBRILE; YOUNG ADULT;

EID: 77958550127     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012740     Document Type: Article

References (46)

1. Ricklin D, Lambris JD (2007) Complement-targeted therapeutics. Nat Biotechnol 25: 1265-1275.
2. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, et al. (2007) The classical complement cascade mediates CNS synapse elimination. Cell 131: 1164-1178.
3. Rahpeymai Y, Hietala MA, Wilhelmsson U, Fotheringham A, Davies I, et al. (2006) Complement: a novel factor in basal and ischemia-induced neurogenesis. EMBO J 25: 1364-1374.
4. Gasque P, Dean YD, McGreal EP, VanBeek J, Morgan BP (2000) Complement components of the innate immune system in health and disease in the CNS. Immunopharmacology 49: 171-186.
5. van Beek J, Elward K, Gasque P (2003) Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection. Ann N Y Acad Sci 992: 56-71.
6. Shen Y, Meri S (2003) Yin and Yang: complement activation and regulation in Alzheimer's disease. Prog Neurobiol 70: 463-472.
7. Ingram G, Hakobyan S, Robertson NP, Morgan BP (2009) Complement in multiple sclerosis: its role in disease and potential as a biomarker. Clin Exp Immunol 155: 128-139.
8. Gendrel M, Rapti G, Richmond JE, Bessereau JL (2009) A secreted complement-control-related protein ensures acetylcholine receptor clustering. Nature 461: 992-996.
9. Roll P, Rudolf G, Pereira S, Royer B, Scheffer IE, et al. (2006) SRPX2 mutations in disorders of language cortex and cognition. Hum Mol Genet 15: 1195-1207.
10. Jager RD, Mieler WF, Miller JW (2008) Age-related macular degeneration. N Engl J Med 358: 2606-2617.
11. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, et al. (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41: 1088-1093.
12. Lambert JC, Heath S, Even G, Campion D, Sleegers K, et al. (2009) Genomewide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41: 1094-1099.
13. Whitney KD, McNamara JO (2000) GluR3 autoantibodies destroy neural cells in a complement-dependent manner modulated by complement regulatory proteins. J Neurosci 20: 7307-7316.
14. Xiong ZQ, Qian W, Suzuki K, McNamara JO (2003) Formation of complement membrane attack complex in mammalian cerebral cortex evokes seizures and neurodegeneration. J Neurosci 23: 955-960.
15. Jamali S, Bartolomei F, Robaglia-Schlupp A, Massacrier A, Peragut JC, et al. (2006) Large-scale expression study of human mesial temporal lobe epilepsy: evidence for dysregulation of the neurotransmission and complement systems in the entorhinal cortex. Brain 129: 625-641.
16. Aronica E, Boer K, van Vliet EA, Redeker S, Baayen JC, et al. (2007) Complement activation in experimental and human temporal lobe epilepsy. Neurobiol Dis 26: 497-511.
17. Gorter JA, van Vliet EA, Aronica E, Breit T, Rauwerda H, et al. (2006) Potential new antiepileptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy. J Neurosci 26: 11083-11110.
18. Loscher W (2002) Current status and future directions in the pharmacotherapy of epilepsy. Trends Pharmacol Sci 23: 113-118.
19. Berkovic SF, McIntosh A, Howell RA, Mitchell A, Sheffield LJ, et al. (1996) Familial temporal lobe epilepsy: a common disorder identified in twins. Ann Neurol 40: 227-235.
20. Cendes F, Lopes-Cendes I, Andermann E, Andermann F (1998) Familial temporal lobe epilepsy: a clinically heterogeneous syndrome. Neurology 50: 554-557.
21. Depondt C, Van Paesschen W, Matthijs G, Legius E, Martens K, et al. (2002) Familial temporal lobe epilepsy with febrile seizures. Neurology 58: 1429-1433.
22. Baulac S, Picard F, Herman A, Feingold J, Genin E, et al. (2001) Evidence for digenic inheritance in a family with both febrile convulsions and temporal lobe epilepsy implicating chromosomes 18qter and 1q25-q31. Ann Neurol 49: 786-792.
23. Claes L, Audenaert D, Deprez L, Van Paesschen W, Depondt C, et al. (2004) Novel locus on chromosome 12q22-q23.3 responsible for familial temporal lobe epilepsy associated with febrile seizures. J Med Genet 41: 710-714.
24. Hedera P, Blair MA, Andermann E, Andermann F, D'Agostino D, et al. (2007) Familial mesial temporal lobe epilepsy maps to chromosome 4q13.2-q21.3. Neurology 68: 2107-2112.
25. Gambardella A, Labate A, Giallonardo A, Aguglia U (2009) Familial mesial temporal lobe epilepsies: clinical and genetic features. Epilepsia 50 Suppl 5: 55-57.
26. Tan NC, Mulley JC, Berkovic SF (2004) Genetic association studies in epilepsy: ''the truth is out there''. Epilepsia 45: 1429-1442.
27. Cavalleri GL, Weale ME, Shianna KV, Singh R, Lynch JM, et al. (2007) Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study. Lancet Neurol 6: 970-980.
28. Vik DP, Amiguet P, Moffat GJ, Fey M, Amiguet-Barras F, et al. (1991) Structural features of the human C3 gene: intron/exon organization, transcriptional start site, and promoter region sequence. Biochemistry 30: 1080-1085.
29. Bruder C, Hagleitner M, Darlington G, Mohsenipour I, Wurzner R, et al. (2004) HIV-1 induces complement factor C3 synthesis in astrocytes and neurons by modulation of promoter activity. Mol Immunol 40: 949-961.
30. Li J, Pircher PC, Schulman IG, Westin SK (2005) Regulation of complement C3 expression by the bile acid receptor FXR. J Biol Chem 280: 7427-7434.
31. Wilson DR, Juan TS, Wilde MD, Fey GH, Darlington GJ (1990) A 58-base-pair region of the human C3 gene confers synergistic inducibility by interleukin-1 and interleukin-6. Mol Cell Biol 10: 6181-6191.
32. Fan JD, Wagner BL, McDonnell DP (1996) Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity. Mol Endocrinol 10: 1605-1616.
33. Juan TS, Wilson DR, Wilde MD, Darlington GJ (1993) Participation of the transcription factor C/EBP delta in the acute-phase regulation of the human gene for complement component C3. Proc Natl Acad Sci U S A 90: 2584-2588.
34. Rice TK, Schork NJ, Rao DC (2008) Methods for handling multiple testing. Adv Genet 60: 293-308.
35. Gebhardt F, Zanker KS, Brandt B (1999) Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1. J Biol Chem 274: 13176-13180.
36. Naylor LH, Clark EM (1990) d(TG)n.d(CA)n sequences upstream of the rat prolactin gene form Z-DNA and inhibit gene transcription. Nucleic Acids Res 18: 1595-1601.
37. Tae HJ, Luo X, Kim KH (1994) Roles of CCAAT/enhancer-binding protein and its binding site on repression and derepression of acetyl-CoA carboxylase gene. J Biol Chem 269: 10475-10484.
38. Yamada N, Yamaya M, Okinaga S, Nakayama K, Sekizawa K, et al. (2000) Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 66: 187-195.
39. Wallace SJ (2004) Febrile seizures. In: Arnold, ed. Epilepsy in Children, 2nd Editions London. pp 122-130.
40. Pitkanen A, Sutula TP (2002) Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol 1: 173-181.
41. Helbig I, Mefford HC, Sharp AJ, Guipponi M, Fichera M, et al. (2009) 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet 41: 160-162.
42. Johnson EW, Dubovsky J, Rich SS, O'Donovan CA, Orr HT, et al. (1998) Evidence for a novel gene for familial febrile convulsions, FEB2, linked to chromosome 19p in an extended family from the Midwest. Hum Mol Genet 7: 63-67.
43. Delic J, Onclercq R, Moisan-Coppey M (1991) Inhibition and enhancement of eukaryotic gene expression by potential non-B DNA sequences. Biochem Biophys Res Commun 181: 818-826.
44. Kauffman MA, Moron DG, Consalvo D, Bello R, Kochen S (2008) Association study between interleukin 1 beta gene and epileptic disorders: a HuGe review and meta-analysis. Genet Med 10: 83-88.
45. Dudbridge F (2008) Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 66: 87-98.
46. Hochberg Y, Benjamini Y (1990) More powerful procedures for multiple significance testing. Stat Med 9: 811-818.